Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data (Q30795793)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data |
scientific article |
Statements
1 reference
Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data (English)
1 reference
A Mills
1 reference
G Crofoot
1 reference
R Ortiz
1 reference
B Rashbaum
1 reference
W Towner
1 reference
D Ward
1 reference
C Brinson
1 reference
R Kulkarni
1 reference
W Garner
1 reference
R Ebrahimi
1 reference
H Cao
1 reference
A Cheng
1 reference
J Szwarcberg
1 reference
1 March 2014
1 reference
1 reference
15
1 reference
51-56
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference